EMR

stock Industrials Specialty Industrial Machinery

Emerson Electric

$139.54 +0.46 (+0.33%) Delayed · quoted 2d ago

Mixed 46% Climbing

What the indicators say

Mixed 2 of 5 trend signals bullish

Momentum · RSI 14 Neutral

0oversold 30overbought 70100

RSI 49 — momentum is balanced between buyers and sellers.

EMA 21 $139.70

Below

Near-term trend is down

SMA 50 $140.40

Below

Medium-term trend is down

SMA 200 $138.89

Above

Long-term trend is up

50 / 200-day

Golden cross

50-day above the 200-day — bullish

Supertrend $146.95

Downtrend

Price is below the Supertrend band — bearish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jul 17

The day open and close within the day's range

Low $137.52 High $142.37

Open: $138.30; -0.56%
Close: $139.54; +0.33%

52-week range where the price sits across its year

52w low $122.64 52w high $165.15

Current: $139.54
Prev close: $139.08

Volume 1.16× the 3-month average

0 avg 2× avg

Today: 3.25M
3-mo avg: 2.80M

Earningscalendar synced from Yahoo 2d ago

Most recent: May 577 days ago
Next expected: Aug 4in 14 days

Recent earnings dates

May 5 77 days ago
Feb 3 168 days ago
Nov 20, 2025 243 days ago
Nov 5, 2025 258 days ago

Past earnings dates come from EMR’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 51d ago

Fair

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Dec 2025 earnings, against the latest price), EMR’s fundamentals read as fair overall.

P/E ratio Fair

34.1x

At 34.1x, investors are paying up; a fair amount of future growth is already in the price.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair

1.51%

A 1.5% yield is modest: a small income on top of whatever the share price does.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Fair

12.7%

A 12.7% margin is solid, in the ordinary range for a profitable company.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Fair

11.3%

A 11.3% return on equity is respectable, in the normal range.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair

5.5%

A 5.5% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity No data

—

Not enough data to compute debt-to-equity.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Weak

0.88

At 0.88, short-term assets fall short of short-term bills; liquidity is tight.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair

+3.0%

Revenue grew 3.0% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Strong

+16.5%

Net income grew 16.5% from the prior year: strong profit expansion.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 51d ago

	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$12.9B	$13.8B	$15.2B	$17.5B	$18.0B
Net income	$2.3B	$3.2B	$13.2B	$2.0B	$2.3B
Diluted EPS	$3.82	$5.41	$22.88	$3.43	$4.04
Dividend / share	$2.02	$2.06	$2.08	$2.10	$2.11
Total assets	$24.7B	$35.7B	$42.7B	$44.2B	$42.0B
Total liabilities	—	—	—	—	—
Shareholder equity	$9.9B	$16.3B	$26.6B	$21.6B	$20.3B

	Q3-2024	Q4-2024	Q1-2025	Q2-2025	Q3-2025	Q4-2025	Q1-2026	Q2-2026
Revenue	$4.4B	$4.6B	$4.2B	$4.4B	$4.6B	$4.9B	$4.3B	$4.6B
Net income	$329.0M	$996.0M	$585.0M	$485.0M	$586.0M	$637.0M	$605.0M	$618.0M
Diluted EPS	$0.57	$1.74	$1.02	$0.86	$1.04	$1.12	$1.07	—
Dividend / share	$0.53	$0.53	$0.53	$0.53	$0.53	$0.53	$0.56	$0.56

Leadershipsynced from SEC 57d ago

Karsanbhai Surendralal Lanca President & CEO · Director
Krishnan Ram R. Executive Vice Pres & COO
Piazza Nicholas J. Senior VP & CPO
Train Michael H. SVP & Chief Sustain Officer
Blinn Mark A Director
Lee Lori M Director
Levatich Matthew S Director
Turley James S Director

Officers and board are drawn from EMR’s recent SEC ownership filings (Forms 3, 4 and 5).

Recent leadership changes

Notable recent eventspast year

May 6 +6.9% one-day move
May 5 Officer or director change reported in an 8-K
Apr 8 +6.0% one-day move
Mar 31 +6.3% one-day move
Mar 30 New 6-month low (-24% off peak)
Mar 12 −5.3% one-day move
Feb 12 −6.3% one-day move
Jan 5 +5.2% one-day move
Nov 14, 2025 Officer or director change reported in an 8-K

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays quarterly Strong

2025 total: $2.14
2026 so far: $1.112 payments
2026 projected: $2.22+3.8% vs 2025

Projection scales EMR’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

May 15 $0.56
Feb 13 $0.56
Nov 14, 2025 $0.56
Aug 15, 2025 $0.53
May 16, 2025 $0.53
Feb 14, 2025 $0.53
Nov 15, 2024 $0.53
Aug 16, 2024 $0.53
May 16, 2024 $0.53
Feb 15, 2024 $0.53
Nov 16, 2023 $0.53
Aug 10, 2023 $0.52
May 11, 2023 $0.52
Feb 16, 2023 $0.52
Nov 9, 2022 $0.52
Aug 11, 2022 $0.52
May 12, 2022 $0.52
Feb 10, 2022 $0.52
Nov 10, 2021 $0.52
Aug 12, 2021 $0.51